SSB
FLNA

Sandy Spring Bank’s Filana Therapeutics FLNA Stock Holding History

Sandy Spring Bank’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,050
Closed -$30.9K – 1274
2024
Q3 		$30.9K Hold
1,050
– – ﹤0.01% 679
2024
Q2 		$13K Hold
1,050
– – ﹤0.01% 839
2024
Q1 		$21.3K Buy
1,050
+1,000
+2,000% +$23K ﹤0.01% 733
2023
Q4 		$1.13K Hold
50
– – ﹤0.01% 1061
2023
Q3 		$832 Hold
50
– – ﹤0.01% 1097
2023
Q2 		$1.23K Hold
50
– – ﹤0.01% 1109
2023
Q1 		$1.21K Hold
50
– – ﹤0.01% 1058
2022
Q4 		$1.48K Hold
50
– – ﹤0.01% 1043
2022
Q3 		$2K Hold
50
– – ﹤0.01% 1052
2022
Q2 		$1K Hold
50
– – ﹤0.01% 1104
2022
Q1 		$2K Buy
+50
New +$2.12K ﹤0.01% 1068
2021
Q4 		– Sell
-500
Closed -$31K – 1251
2021
Q3 		$31K Buy
+500
New +$41.7K ﹤0.01% 666

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Sandy Spring Bank's FLNA Position: Q4 2024 in Review

Sandy Spring Bank sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 1,050 shares — an estimated $30.9K sold.

Sandy Spring Bank first reported a position in FLNA in Q3 2021 and held it in 12 quarters. The position peaked at $31K in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Sandy Spring Bank reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 1,050 Filana Therapeutics shares in Q4 2024, an estimated $30.9K.
  • Sandy Spring Bank first reported a position in Filana Therapeutics in Q3 2021 and held it in 12 quarters.
  • Sandy Spring Bank's Filana Therapeutics position peaked at $31K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Sandy Spring Bank's 13F filing for Q4 2024, filed 11 Feb 2025.